Live Date:
January 17, 2023
7:15 PM CST
The National Institute of Health now estimates that there are well over thirty seven million diabetics in the United States alone, a number well over eleven percent of our population. The associated multiple organ system disease is responsible for over 327 billions dollars in direct and indirect medical costs, and over one hundred forty thousand lower extremity amputations yearly in the United States. As health care professionals have begun to appreciate the economic and pathologic burden that diabetes imparts on our society, there has been a growth in both the understanding and treatment of the responsible pathologic disorders. The goal of this monograph is to provide an evidence supported foundation to better understand the pathophysiology that leads to the development of neuropathic (Charcot) Foot Arthropathy, and provide insight into developing a treatment plan for addressing this complex disease process that presents in a highly co-morbid patient population.
- Identify pathophysiology of diabetic organ disease
- Examine a new paradigm for Charcot Foot
- Learn about a modern approach to treatment of Charcot Foot
